Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1005

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 3
Chunk 1005
---
 4.53   Granted   17,005    54.62    -    10.00   Exercised   -    -    -    -   Forfeited   -    -    -    -   Expired   -    -    -    -   Options outstanding, December 31, 2024   17,637   $64.06   $-    9.38                                                 Options vested and exercisable, December 31, 2024   4,437   $116.07   $-    8.73  

The following table summarizes the Company’s
stock option activities during the year ended December 31, 2023:

     Number of Options   Weighted Average Exercise Price   Aggregate Intrinsic Value   Weighted Average Remaining Contractual Life  (Years)   Options outstanding, December 31, 2022   -   $-   $           -    -   Granted   632    318.00    -    5.00   Exercised   -    -    -    -   Forfeited   -    -    -    -   Expired   -    -    -    -   Options outstanding, December 31, 2023   632   $318.00   $-    4.53                          Options vested and exercisable, December 31, 2023   632   $318.00   $-    4.53  

The aggregate intrinsic value in the tables above
reflects the difference between the Company’s closing stock price on the last trading day of the period and the exercise price
of the options, multiplied by the number of in-the-money stock options. The intrinsic value of stock options changes based on the price
of the Company’s common stock.

On July 16, 2024, the effective date of shareholder
approval to increase the number of shares available under the